Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for lung cancer.

J M McGee1

  • 1Department of Surgery, Oral Roberts University, School of Medicine, Tulsa, Oklahoma.

Seminars in Surgical Oncology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Early lung cancer detection through yearly chest X-rays and sputum cytology can improve survival. However, overall mortality rates remain unchanged, necessitating further research into novel screening methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polarographic reduction of carbon dioxide; description and interpretation of the waves.

Journal of the American Chemical Society·2010
Same author

Polarographic studies on extracted chlorophylls.

Journal of the American Chemical Society·2010
Same author

Laparoscopic exploration for the clinically undetected hernia in infancy and childhood.

American journal of surgery·2002
Same author

Comparison of melanoma antigens in whole tumor vaccine to those from IIB-MEL-J cells.

Cancer biotherapy & radiopharmaceuticals·2000
Same author

Adjuvant radiation after modified radical mastectomy for breast cancer fails to prolong survival.

The American surgeon·2000
Same author

Phyllodes tumors of the breast: a review of 32 cases.

The American surgeon·2000
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Diagnostic Imaging

Background:

  • Lung cancer incidence is rising globally.
  • Early detection significantly improves patient survival rates.
  • Current screening relies on chest X-rays and sputum cytology.

Purpose of the Study:

  • To evaluate the effectiveness of current lung cancer screening methods.
  • To explore the potential of novel screening techniques for reducing lung cancer mortality.
  • To identify high-risk populations for targeted screening interventions.

Main Methods:

  • Review of existing lung cancer screening programs.
  • Analysis of survival data in relation to early detection.
  • Assessment of current screening modalities like chest X-ray and sputum cytology.

Related Experiment Videos

  • Consideration of emerging technologies including serum markers, monoclonal antibodies, and automated cytology.

    • Main Results:

    • Survival rates have increased, particularly with early detection.
    • Overall mortality rates have not significantly decreased across all subsets.
    • Yearly chest X-rays and sputum cytology are recommended for high-risk individuals.
    • Novel screening methods require further clinical validation.

    Conclusions:

    • Current screening methods improve survival but not overall mortality.
    • High-risk patients (age >65, >20 pack-year smoking history) benefit from annual screening.
    • Emerging technologies need rigorous testing in clinical trials before widespread adoption.